For Patients and Visitors
Vanderbilt University Medical Center: For Employees, Researchers, and Students

2008-2009 Publications

*Illustrate inter- or intra-programmatic collaborations
+ and italicized names: One of the ten best publications (PDF attached).

1. Aiken C. Cell-free assays for HIV-1 uncoating. Methods Mol Biol.2009; 485:41-53. PubMed PMID: 19020817.

2. *Ambrose Z, Compton L, Piatak M Jr, Lu D, Alvord WG, Lubomirski MS, Hildreth JE, Lifson JD, Miller CJ, KewalRamani VN. Incomplete protection against simian immunodeficiency virus vaginal transmission in rhesus macaques by a topical antiviral agent revealed by repeat challenges. J Virol. 2008 Jul; 82(13):6591- Epub 2008 Apr 23. PubMed PMID: 18434406; PubMed Central PMCID: PMC2447098.

3. Antons AK, Wang R, Kalams SA, Unutmaz D. Suppression of HIV-specific and allogeneic T cell activation by human regulatory T cells is dependent on the strength of signals. PLoS One. 2008 Aug 13; 3(8):e2952. PubMed PMID: 18698349; PubMed Central PMCID: PMC2490715.

4. Bartlett EC, Zavaleta C, Fernández C, Razuri H, Vilcarromero S, Vermund SH, Gotuzzo E. Expansion of HIV and Syphilis into the Peruvian Amazon: A survey of four communities of an indigenous Amazonian ethnic group. Int J Infect Dis. 2008; 12(6):e89-94. PubMed PMID: 18760648; PubMed Central PMCID: PMC2610365.

5. Basu J, Romney SL, Angeletti RH, Vermund SH, Nieves E, Kadish AS, Mikhail MS, Orr GA. Human immunodeficiency virus antigens and RNA in HIV-seronegative women with cervical intraepithelial neoplasia. AIDS Res Hum Retrovir uses 2009, March 17. [Epub ahead of print].

6. Bussmann H, Wester CW, Ndwapi N, et al. Five Year Outcomes of Initial Patients Treated in Botswana's National Antiretroviral Treatment Program. AIDS. 2008; 22 (17): 2303-2311

7. Bussmann H, Wester CW, Thomas AM, et al. Response to ZDV/ddl containing HAART among HIV-1Subtype C Infected Adults in Botswana: Two-Year Outcomes from a Randomized Clinical Trial. Accepted for publication 26 January 2009 JAIDS, in press; manuscript #V-10754.

8. *Carlucci JG, Kamanga A, Sheneberger R, Shepherd BE, Jenkins CA, Spurrier J, Vermund SH. Predictors of adherence to antiretroviral therapy in rural Zambia. J Acquir Immune Defic Syndr 2008, 47(5):615-22. PubMed PMID: 18209678

9. *Charles M, Noel F, Leger P, Severe P, Riviere C, Beauharnais CA, Miller E, Rutledge J, Bang H, Shealey W, D’Aquila RT, Gulick RM, Johnson Jr. WD, Wright PF, Pape JW, Fitzgerald DW. Antiretroviral therapy for HIV-1 Infected Adolescents and Youth in Haiti. Bulletin of the World Health Organization. 2008 Dec; 86(12):970-7.

10. *Devasia RA, Blackman A, Gebretsadik T, Griffin M, Shintani A, May C, Smith T, Hooper N, Maruri F, Warkentin J, Mitchel E, Sterling TR. Fluoroquinolone Resistance in M. tuberculosis: The Effect of Duration and Timing of Fluoroquinolone Exposure. Am J Respir Crit Care Med. 2009 May 29. [Epub ahead of print] PubMed PMID: 19483111.

11. Donahue JP, Vetter ML, Mukhtar NA, D’Aquila RT. The HIV-1 Vif PPLP Motif is Necessary for Human APOBEC3G Binding and Degradation. Virology. 2008 Jul 20; 377(1):49-53. Epub 2008 May 21. PubMed PMID: 18499212; PubMed Central PMCID: PMC2474554.

12. *Dorjgochoo T, Noel F, Deschamps MM, Theodore H, Charles S, Dupont W, Wright PF, Fitzgerald DW, Vermund SH, Pape JW. Risk factors for HIV infection among Haitian adolescents and young adults seeking counseling and testing in Port-au-Prince. J Acquir Immune Defic Syndr 2009; 49; in press.

13. *Goldman JD, Cantrell RA, Mulenga LB, Tambatamba BC, Reid S, Levy J, Limbada M, Taylor A, Saag MS, Vermund SH, Stringer JSA, Chi BH. Simple adherence assessments to predict virologic suppression among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy. AIDS Res Hum Retrovir 2008; 24(8):1031-5.

14. *Haas DW, Gebretsadik T, Mayo G, Menon UN, Acosta EP, Shintani A, Floyd M, Stein CM, Wilkinson GR. Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African Americans. J Infect Dis. 2009 Mar 15; 199(6):872-80. PubMed PMID: 19239339.

15. Haas DW, Koletar SL, Laughlin L, Kendall MA, Suckow C, Gerber JG, Zolopa AR, Bertz R, Child MJ, Hosey L, Alston-Smith B, Acosta EP; A5213 Study Team. Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir. J Acquir Immune Defic Syndr. 2009 Mar 1; 50(3):290-3. PubMed PMID: 19194314; PubMed Central PMCID: PMC2653210.

16. Hulgan T. High-concentration capsaicin reduced pain in patients with HIV-associated polyneuropathy. Evid Based Med. 2008 Dec; 13(6):183. PubMed PMID: 19043041.

17. *Hulgan T, Tebas P, Canter JA, Mulligan K, Haas DW, Dubé M, Grinspoon S, Robbins GK, Motsinger AA, Kallianpur AR; AIDS Clinical Trials Group 384 and A5005s Study Teams. Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy. J Infect Dis. 2008 Mar 15; 197(6):858-66. Erratum in: J Infect Dis. 2008 Jun 1; 197(11):1630. PubMed PMID: 18419350.

18. *Jia Y, Lu F, Sun XH, Zeng G, Lu L, Liu W, Vermund SH. Risk factors in HIV infections among injection drug users in three HIV highly endemic regions in China. Harm Reduction J 2008; in press.

19. *Jia Y, Lu F, Zeng G, Sun X, Xiao Y, Lu L, Liu W, Ni W, Ou S, Li C, Liu J, Wu P, Vermund SH. Predictors of HIV infection and prevalence for syphilis infection among injection drug users in China: Community-based surveys along major drug trafficking routes. Harm Reduct J. 2008, 25; 5:29. 2008 Aug 25; 5:29. PubMed PMID: 18724872; PubMed Central PMCID: PMC2556669.

20. *Jia Y, Lu F, Sun X, Vermund SH. Sources of data for improved surveillance of HIV/AIDS in China. Southeast Asian J Trop Med Public Health. 2007 Nov; 38(6):1041-52. PubMed PMID: 18613545.

21. *Jia Y, Sun J, Fan L, Song D, Tian S, Yang Y, Jia M, Lu L, Sun X, Zhang S, Kulczycki A, Vermund SH. Estimates of HIV prevalence in a highly endemic area of China: Dehong Prefecture, Yunnan Province. Int J Epidemiol. 2008; 37(6): 1287-96. PubMed PMID: 18922804; PubMed Central PMCID: PMC2638873.

22. *Jia Y, Sun J, Lu F, Song D, Tian S, Yang Y, Jia M, Lu L, Sun X, Zhang SG, Kulczycki A, Vermund SH. Estimates of HIV prevalence in a highly endemic area of China: Dehong Prefecture, Yunnan Province. International Journal of Epidemiology. 2008; 37(6): 1-10.

23. *Kallianpur AR, Hulgan T. Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy. Pharmacogenomics. 2009 Apr; 10(4):623-37. PubMed PMID: 19374518; PubMed Central PMCID: PMC2706211.

24. Kapina M, Reid C, Cyrus-Cameron E, Roman K, Kwiecien A, Weiss SM, Vermund SH. HIV Incidence rates and risk factors for urban women in Zambia: Preparing for a microbicide clinical trial. Sex Transm Dis 2009, Jan 23. [Epub ahead of print]

25. * Khatua AK, Taylor HE, Hildreth JE, Popik W. Exosomes packaging APOBEC3G confer human immunodeficiency virus resistance to recipient cells. J Virol. 2009 Jan; 83(2):512-21. Epub 2008 Nov 5. PubMed PMID: 18987139; PubMed Central PMCID: PMC2612372.

26. *Kitabwalla M, Ansari AA, Villinger F, Akeefe H, Conner AP, Mayne AE, Hildreth JE. Delipidated retroviruses as potential autologous therapeutic vaccines—a pilot experiment. Exp Biol Med (Maywood). 2008 Jun; 233(6):732-40. Epub 2008 Apr 11. PubMed PMID: 18408147.

27. *Koelsch KK, Liu L, Haubrich R, May S, Havlir D, Günthard HF, Ignacio CC, Campos-Soto P, Little SJ, Shafer R, Robbins GK, D’Aquila RT, Kawano Y, Young K, Dao P, Spina CA, Richman DD, Wong JK. Dynamics of Total, Linear Nonintegrated, and Integrated HIV-1 DNA In Vivo and In Vitro. Journal of Infectious Diseases. 2008; 197:411-9

28. + Kuhn L, Aldrovandi GM, Sinkala M, Kankasa C, Semrau K, Mwiya M, Kasonde P, Scott N, Vwalika C, Walter J, Bulterys M, Tsai WY, Thea DM. Zambia Exclusive Breastfeeding Study (Cited in N Engl J Med and PubMed as “ZEBS collaborators”: Abrams E, Colton T, Fawzi W, Kapiga S, Chomba E, Allen S, Luo C, Mofenson L, Piwoz E, Ryan K, Simon J, Stein Z, Stringer J, Vermund S): Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med 2008; 359(2):130-41.

29. *Kuritzkes DR, Lalama CM, Ribaudo HJ, Marcial M, Meyer WA, III, Shikuma C, Johnson VA, Fiscus SA, D'Aquila RT, Schackman BR, Acosta EP, Gulick RM. Pre-existing non-nucleoside reverse transcriptase inhibitor resistance predicts virologic failure of an efavirenz- based regimen in treatment-naïve HIV-1-infected subjects. Journal of Infectious Diseases. 2008; 197:867-70

30. Lemly DC, Shepherd BE, Hulgan T, Rebeiro P, Stinnette S, Blackwell RB, Bebawy S, Kheshti A, Sterling TR, Raffanti SP. Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care. J Infect Dis. 2009 Apr 1;199(7):991-8. PubMed PMID: 19220139.

31. *Li A, Varangrat A, Wimonsate W, Chemnasiri T, Sinthuwattanawibool C, Phanuphak P, Jommaroeng R, Vermund SH, van Griensven F. Sexual Behavior and Risk Factors for HIV Infection among Homosexual and Bisexual Men in Thailand. AIDS Behav. 2008; in press, Aug 30. Epub 2008 Aug 30. PubMed PMID: 18758936.

32. *Li AH, Phanuphak N, Sahasrabuddhe VV, Chaithongwongwatthana S, Vermund SH, Jenkins CA, Shepherd BE, Teeratakulpisarn N, van der Lugt J, Avihingsanon A, Ruxrungtham K, Shikuma C, Phanuphak P, Ananworanich J. Anal squamous intraepithelial lesions among HIV-positive and HIV-negative men who have sex with men in Thailand. Sex Transm Infect. 2009 Jun 11. [Epub ahead of print] PubMed PMID: 19525263.

33. *Li CM, Ding XB, Liu JB, Xiao Y, Jia Y. HIV and syphilis infections among men who have sex with men in Chongqing municipality, China. Chin J Epidemiol. 2009 Feb; 30(2): 22-6.

34. *Li X, Shi W, Li D, Ruan Y, Jia Y, Vermund SH, Zhang X, Wang C, Liu Y, Yu M, Xing H, Hong K, Shao Y. Predictors of unprotected sex among men who have sex with men in Beijing, China. Southeast Asian J Trop Med Public Health 2008; 39(1):99-108.

35. *Liu J, Zhang L, Lai W, Liao F, Zeng Y, Li L, Hu Y, Xiao Y, Vermund SH, Jia Y. Needle and/or injection equipment sharing in new and long-term injection drug users in Sichuan, China. Chin J Epidemiol. 2009 July;30(7).

36. *Liu L, Luan R, Yang W, Zhang L, Zhang J, Nan L, Huang J, Hu Y, Mao G, Feng L, Gong Y, Vermund SH, Jia Y. Projecting dynamic trends for HIV/AIDS in a highly endemic area of China: Estimation models for Liangshan Prefecture, Sichuan Province. Curr HIV Res 2009 July;7(4).

37. *Lu F, Jia Y, Bin S, Li C, Limei S, Kristensen S, Sun X, Xiao Y, Liu J, Li D, Qu S, Vermund SH. Predictors for casual sex and/or infection among sexually transmitted disease clinic attendees in China. Intern J STD AIDS. 2009; 20(4): 241-8.

38. *Lu F, Jia Y, Li CM, Liu W, Sun XH, Li CM, Liu JB, Kristensen S, Vermund SH. Risk factors for casual sex and/or infection among patients attending sexually transmitted disease clinics in China. Int J STD & AD. 2008 (accepted).

39. *Lu F, Jia Y, Sun X, Wang L, Liu W, Xiao Y, Zeng G, Li CM, Liu JB, Cassell H, Chen HT, Vermund SH. Prevalence of HIV infection and predictors for syphilis infection among female sex workers in southern China. Southeast Asian J Trop Med Public Health. 2009; 40(2): 263-72

40. *Megazzini KM, Chintu N, Vermund SH, Redden DT, Krebs DW, Simwenda M, Tambatamba B, Sinkala M, Stringer JS. Predictors of Rapid HIV Testing Acceptance and Successful Nevirapine Administration in Zambian Labor Wards. J Acquir Immune Defic Syndr. 2009 Jun 26. [Epub ahead of print] PubMed PMID: 19568175.

41. Modjarrad K, Chamot E, Vermund SH. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression AIDS 2008; in press.

42. Mujugira A, Wester CW, Kim SA, et al. Patients with Advanced HIV-1 Infection Initiating Antiretroviral Therapy in Botswana: Treatment response and mortality. AIDS Research and Human Retroviruses. 2009; 25 (2): 127-133. PubMed PMID: 18832881; PubMed Central PMCID: PMC2661869.

43. *Mwanahamuntu MH, Sahasrabuddhe VV, Stringer JSA, Parham GP. Integrating cervical cancer prevention in HIV/AIDS treatment and care programs. Bulletin of World Health Organization. 2008; 86(8): D-E

44. *Mwinga K, Vermund SH, Chen YQ, Mwatha A, Read JS, Urassa W, Carpenetti N, Valentine M, Goldenberg RL. Hematology and biochemistry in African HIV-infected and uninfected pregnant women and their infants: HIV Prevention Trials Network 024 protocol. BMC Pediatrics 2009; provisional acceptance.

45. Pepper T, Joseph P, Mwenya C, McKee GS, Haushalter A, Carter A, Warkentin J, Haas DW, Sterling TR. Normal chest radiography in pulmonary tuberculosis: implications for obtaining respiratory specimen cultures. Int J Tuberc Lung Dis. 2008 Apr;12(4):397-403. PubMed PMID: 18371265.

46. Pettit AC, Barkanic G, Stinnette S, Rebeiro P, Blackwell R, Raffanti SP, Shepherd BE, Sterling TR. Potentially preventable tuberculosis among HIV-infected persons in the era of highly active antiretroviral treatment. Int J Tuberc Lung Dis. 2009 Mar;13(3):355-9. PubMed PMID: 19275796.

47. *Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, Stringer JS, Parham GP. Management of cryotherapy-ineligible women in a “screen and treat” cervical cancer prevention program targeting HIV-infected women in Zambia: Lessons from the field. Gynecologic Oncology. 2008; 110(3): 402-407

48. *Potter D, Goldenberg RL, Chao A, Sinkala M, Degroot A, Stringer JSA, Bulterys M, Vermund SH. Do targeted HIV programs improve overall care for pregnant women? Antenatal syphilis management in Zambia before and after implementation of prevention of mother-to-child HIV transmission programs. J Acquir Immune Defic Syndr 2008; 47(1):79-85.

49. +Qi M, Yang R, Aiken C. Cyclophilin A-dependent restriction of human immunodeficiency virus type 1 capsid mutants for infection of nondividing cells. J Virol. 2008 Dec;82(24):12001-8. Epub 2008 Oct 1. PubMed PMID: 18829762; PubMed Central PMCID: PMC2593355.

50. Qi M, Aiken C. Nef enhances HIV-1 infectivity via association with the virus assembly complex. Virology. 2008 Apr 10;373(2):287-97. Epub 2008 Jan 14. PubMed PMID: 18191978; PubMed Central PMCID: PMC2440657.

51. *Qian HZ, Li Q, Yao H, Ruan R, Kristensen S, Schumacher JE, Pan SW, Shao Y, Kimerling ME. Tuberculosis co-morbidity and perceptions about health care among HIV-infected plasma donors in rural China. Southeast Asian J Trop Med Public Health; 2009; 40(1): 108-112. PubMed PMID: 19323042

52. Qian HZ, Vermund SH. Antiretroviral therapy for former plasma donors in China: Saving lives when human immunodeficiency virus prevention fails. Clin Infect Dis 2008; 47(6):834-6.

53. *Qian HZ, Wang N, Dong S, Chen H, Zhang Y, Chamot E, Yang Z, Shi X, Gao J, Vermund SH, Shao Y. Association of misconceptions about HIV transmission and discriminatory attitudes in rural China. AIDS Care 2008; 19(10): in press.

54. * Rebeiro PF, Kheshti A, Bebawy SS, Stinnette SE, Erdem H, Tang Y-W, Sterling TR, Raffanti SP, D’Aquila RT. Increased Detectability of Plasma HIV-1 RNA After Introduction of a New Assay and Altered Specimen Processing Procedures. Clin. Infect. Dis. 2008;47(10):1354-7.PubMed PMID 18922071; PubMed Central PMCID: PMC2605467

55. Rold CJ, Aiken C. Proteasomal degradation of TRIM5alpha during retrovirus restriction. PLoS Pathog. 2008 May 23;4(5):e1000074. PubMed PMID: 18497858; PubMed Central PMCID: PMC2374908.

56. *Ruan Y, Luo F, Jia Y, Li X, Li Q, Liang H, Zhang X, Li D, Shi W, Freeman JM, Vermund SH, Shao Y. Risk factors for syphilis and prevalence of HIV, hepatitis B and C among men who have sex with men in Beijing, China: Implications for HIV prevention. AIDS Behav 2008; in press Dec 12. [Epub ahead of print]

57. *Ruan Y, Qian HZ, Li D, Shi W, Li Q, Liang H, Yang Y, Luo F, Vermund SH, Shao Y. Willingness to be circumcised for preventing HIV among Chinese men who have sex with men. AIDS Patient Care STDS. 2009 May; 23(5):315-21. [Epub ahead of print]

58. *Ruan Y, Zhang L, Wei J, Qian HZ, Ning S, Xu J, Jia S, Xing H, Yin L, Zhang Y, Song Y, Shao Y. Risk Factors for Death in Subjects with Transfusion-Related HIV Infection in Rural China. AIDS Patient Care STDs 2008; 22:95-7.

59. *+ Sadagopal S, Braunstein M, Hager CC, Wei J, Daniel AK, Bochan MR, Crozier I, Smith NE, Gates HO, Barnett L, Van Kaer L, Price JO, Blackwell TS, Kalams SA, Kernodle DS. Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG. PLoS One. 2009;4(5):e5531. Epub 2009 May 13.

60. *+Sadagopal S, Lorey SL, Barnett L, Basham R, Lebo L, Erdem H, Haman K, Avison M, Waddell K, Haas DW, Kalams SA. Enhancement of human immunodeficiency virus (HIV)-specific CD8+ T cells in cerebrospinal fluid compared to those in blood among antiretroviral therapy-naive HIV-positive subjects. J Virol. 2008 Nov;82(21):10418-28. Epub 2008 Aug 20. PubMed PMID: 18715919; PubMed Central PMCID: PMC2573184.

61. *+Schneidewind A, Tang Y, Brockman MA, Ryland EG, Dunkley-Thompson J, Steel-Duncan JC, St John
MA, Conrad JA, Kalams SA, Noel F, Allen TM, Christie CD, Feeney ME. Maternal transmission of HIV escape mutations subverts HLA-B57 immunodominance but facilitates viral control in the haploidentical infant. J Virol. 2009 Jun 10. [Epub ahead of print] PubMed PMID: 19515764.

62. Scorpio DG, Ruben DS, Liao Z, Hildreth JE, Fletcher CA. Cervicovaginal evaluation in macaques used as a model for topical microbicide safety studies. J Med Primatol. 2008 Feb;37 Suppl 1:65-73. PubMed PMID: 18269532.

63. Shepherd BE, Sterling TR, Moore RD, Raffanti SP, Hulgan T. Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiators. J Clin Epidemiol. 2009 Jul;62(7):729-37. Epub 2008 Dec 23. PubMed PMID: 19108987.

64. +Simons BC, Vancompernolle SE, Smith RM, Wei J, Barnett L, Lorey SL, Meyer-Olson D, Kalams SA. Despite biased TRBV gene usage against a dominant HLA B57-restricted epitope, TCR diversity can provide recognition of circulating epitope variants. J Immunol. 2008 Oct 1;181(7):5137-46. PubMed PMID: 18802118.

65. *Sinkala E, Gray S, Zulu I, Mudenda V, Zimba L, Vermund SH, Drobniewski F, Kelly P. Clinical and ultrasonographic features of abdominal tuberculosis in HIV positive adults in Zambia. BMC Infect Dis. 2009; 9(1):44. (online journal)

66. *Tang LM, Xia Y, Sun JP, Lu F, Jia Y, Sun J. Impact factors of AIDS knowledge and attitude among students in HIV lower-prevalent provinces (or municipality or autonomous regions) in China, Chin J Public Health. 2008; 24(3): 313-317.

67. *+ Tang Y, Leao IC, Coleman EM, Broughton RS, Hildreth JE. Deficiency of Niemann-Pick type C-1 Protein Impairs HIV-1 Release and Results in Gag Accumulation in Late Endosomal/Lysosomal Compartments. J Virol. 2009 May 27. [Epub ahead of print] PubMed PMID: 19474101.

68. *+Varthakavi V, Heimann-Nichols E, Smith RM, Sun Y, Bram RJ, Ali S, Rose J, Ding L, Spearman P. Identification of calcium-modulating cyclophilin ligand as a human host restriction to HIV-1 release overcome by Vpu. Nat Med. 2008 Jun;14(6):641-7. Epub 2008 May 25. PubMed PMID: 18500349; PubMed Central PMCID: PMC2652483.

69. *Verbitski SM, Gourdin GT, Ikenouye LM, McChesney JD, Hildreth J. Detection of Actaea racemosa adulteration by thin-layer chromatography and combined thin-layer chromatography-bioluminescence. J AOAC Int. 2008 Mar-Apr;91(2):268-75. PubMed PMID: 18476337.

70. *Vermund SH, Allen KL, Karim QA. HIV-prevention science at a crossroads: advances in reducing sexual risk. Curr Opin HIV AIDS. 2009 Jul;4(4):266-73.PubMed PMID: 19532063.

71. *Vermund SH, Krogstad P, From the Guest Editors. Prevention of Mother-to-Child HIV Transmission and Management of Pediatric HIV Infection in Jamaica. West Indian Med J 2008; 57; in press.

72. + Vermund SH, Qian HZ. Circumcision and HIV Prevention among Men Who Have Sex with Men: No Final Word. JAMA 2008; 300:1698-700

73. Vetter ML, D'Aquila RT. Cytoplasmic APOBEC3G Restricts Incoming Vif-positive HIV-1 and Increases 2-LTR Circle Formation In Activated T Helper Subtype Cells. J Virol. 2009 Jun 17. [Epub ahead of print]

74. +Vetter ML, Johnson ME, Antons AK, Unutmaz D, D’Aquila RT. Differences in APOBEC3G Expression in CD4+ T Helper Lymphocyte Subtypes Modulate HIV-1 Infectivity. PLoS Pathogens, Feb;5(2):e1000292. Epub 2009 Feb 6.

75. Sahasrabuddhe V, Mehendale, S, Female sex workers and the HIV/AIDS Epidemic in India. Book chapter in Sahni R, Kalyan Shankar V, Apte H, eds. Prostitution and Beyond: an analysis of sex work in India. Sage Publications, London, UK. 2008

76. Wagner LJ, Hilker KA, Hepworth JT, Wallston KA. Cognitive Adaptability as a Moderator of Expressive Writing Effects in an HIV Sample. AIDS Behav. 2008 Jul 8.[Epub ahead of print] PubMed PMID: 18607714.

77. *Xiao Y, Ding X, Li CM, Liu JB, Sun J, Jia Y. Prevalence and correlates of HIV and syphilis infections among men who have sex with men in Chongqing Municipality, China. Sex Transm Dis. 2009. In press

78. *Xiao Y, Li CM, Lu F, Tang HL, Zhang DP, Jin CR, Jia Y, Sun JP. Factors and changes of condom use among men who have sex with men in 16 Cities of China. Chin J AIDS STD. 2008 14(2): 133-6.

79. *Xiao Y, Sun JP, Li CM, Lu F, Allen KL, Vermund SH, Jia Y. Prevalence and correlates of HIV and syphilis infections among men who have sex with men in seven provinces in China with historically low HIV prevalence. JAIDS. 2009. In press.

80. *Yin L, Zhang Y, Qian HZ, Rui B, Zhang L, Zhu J, Guan Y, Wang Y, Li Q, Ruan Y, Shao Y. Willingness of Chinese injection drug users to participate in HIV vaccine trials. Vaccine 2008; 26:762-8.

81. *Zhang L, Liu J, Lai WH, Feng L, Zeng Y, Liu L, Hu Y, Li J, Xiao Y, Jia Y. Correlates of AIDS-related knowledge among new and long-term injection drug users in Sichuan, China. Journal of Preventive Medicine Information (in Chinese). 2009. In press.

82. *Zhang L, Liu J, Lai WH, Feng L, Zeng Y, Liu L, Hu Y, Li J, Xiao Y, Jia Y. Correlates of AIDS-related knowledge among new and long-term injection drug users in Sichuan, China. Journal of Preventive Medicine Information (in Chinese). 2009 July, in press.

83. *Zhang L, Zhu J, Rui B, Zhang Y, Zhang L, Yin L, Ruan Y, Qian HZ, Shao Y. High HIV risk among Uigur minority ethnic drug users in northwestern China. Trop Med Int Health 2008; 13(6):814-7.

84. *Zhang Q, Wang L, Jiang Y, Fang L, Pan P, Gong S, Yao J, Tang YW, Vermund SH, Jia Y. Early infant human immunodeficiency virus type 1 detection suitable for resource-limited settings with multiple circulating subtypes by use of nested three-monoplex DNA PCR and dried blood spots. J Clin Microbiol 2008; 46(2):721-6.

85. Tsogzolmaa Dorjgochoo, MD, MPH, Francine Noel, MD, MSCI, Marie Marcelle Deschamps, MD, Harry Theodore, MD, William Dupont, PhD, Peter F. Wright, MD, Dan W. Fitzgerald, MD, Sten H. Vermund, MD, PhD and Jean W. Pape, MD. Risk Factors for HIV Infection Among Haitian Adolescents and Young Adults Seeking Counseling and Testing in Port-au-Prince. Epidemiology and Social Science. Dec. 2009

86. Cynthia S. Tsai, MPH; Bryan E. Shepherd, PhD; Sten H. Vermund, MD, PhD. Does douching increase risk for sexually transmitted infections? A prospective study in high-risk adolescents. American Journal of Obstetrics & Gynecology, Jan. 2009



Copyright © 2015 by Vanderbilt University Medical Center    |    1211 Medical Center Drive    |    Nashville, TN 37232    |    (615) 322-5000
Vanderbilt University is committed to principles of equal opportunity and affirmative action.
This page was last updated September 21, 2011 and is maintained by Gina Perez